eIF5A2 regulates the resistance of gastric cancer cells to cisplatin via induction of EMT

Cisplatin is the first-line chemotherapy drug for gastric cancer (GC), but treatment failure often occurs due to development of resistance. The mechanism of cisplatin resistance remains a mystery. Eukaryotic translation initiation factor 5A2 (eIF5A2) is an important tumor-promoting factor and has be...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Am J Transl Res
Main Authors: Sun, Jiancheng, Xu, Zhiyuan, Lv, Hang, Wang, Yiping, Wang, Lijing, Ni, Yixiu, Wang, Xiaofeng, Hu, Can, Chen, Shangqi, Teng, Fei, Chen, Wei, Cheng, Xiangdong
Formato: Artigo
Idioma:Inglês
Publicado em: e-Century Publishing Corporation 2018
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6325524/
https://ncbi.nlm.nih.gov/pubmed/30662669
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados